DBT, Cancer Research UK sign MoU for cancer research

19 November 2018 | News

The India-UK Cancer Research Initiative was launched recently at the Inaugural Researchers’ Summit in New Delhi.

A Memorandum of Understanding (MoU) for the partnership between Department of Biotechnology (DBT) and Cancer Research UK for the India-UK Cancer Research Initiative was signed recently in New Delhi. The India-UK Cancer Research Initiative is a collaborative 5-year bilateral research initiative by the Department of Biotechnology, Ministry of Science & Technology, India and Cancer Research UK (CRUK) that will focus on affordable approaches to cancer. Both CRUK and DBT will invest £5 million each in this 5-year pilot, and seek further investment from other potential funding partners.

The India-UK Cancer Research Initiative will identify a core set of research challenges that address issues of affordability, prevention and care of cancer by bringing together leading Indian and UK experts across clinical research, demographic research, new technologies and physical sciences. The initiative will provide funding to develop new research alliances and undertake impactful research to enable significant progress against cancer outcomes.

Speaking at the launch of this initiative, Secretary, DBT, Dr. Renu Swarup, said, “Cancer is a global epidemic that requires radically new approaches through inter-disciplinary and multi-national efforts. The India-UK Cancer Research Initiative will provide a catalyzing platform for scientists and researchers in the United Kingdom and India to co-create solutions for affordable cancer care that improve cancer outcomes around the globe. At DBT our priority is to apply science to solving complex challenges that benefit all humanity and we are glad to be partnering with CRUK to support research across all stages of cancer from prevention to cure to address the formidable challenge of cancer.”


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account